![](/wp-content/uploads/2024/05/Screenshot-2024-05-07-at-5.04.02%E2%80%AFPM.png)
$599
Madrigal, Vertex, Ionis, Esperion, and Scholar Rock Q1 ‘24 Earnings; Tandem t:connect App Recalled
A series of cardiometabolic-related news items have been observed from Madrigal, Vertex, Ionis, Esperion, Scholar Rock, and Tandem. Below, FENIX provides highlights and insights for the respective news items.